MARKET

ASRT

ASRT

Assertio Therapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6467
+0.0116
+1.83%
Closed 18:00 04/02 EDT
OPEN
0.6324
PREV CLOSE
0.6351
HIGH
0.6520
LOW
0.6210
VOLUME
400.50K
TURNOVER
--
52 WEEK HIGH
5.76
52 WEEK LOW
0.5500
MARKET CAP
52.57M
P/E (TTM)
-0.2335
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ASRT stock price target is 3.500 with a high estimate of 3.500 and a low estimate of 3.500.

EPS

ASRT News

More
  • Does Assertio Therapeutics, Inc. (NASDAQ:ASRT) Have A Particularly Volatile Share Price?
  • Simply Wall St. · 1d ago
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36
  • Wayne-based drug company enters into $17.5M merger deal
  • American City Business Journals · 03/17 16:41
  • Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies WLTW, TTPH, ASRT, MEET
  • GlobeNewswire · 03/17 15:15

Industry

Pharmaceuticals
+2.64%
Pharmaceuticals & Medical Research
+2.80%

Hot Stocks

Symbol
Price
%Change

About ASRT

Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include Gralise (gabapentin), Cambia (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium liquid filled capsules). Its Gralise (gabapentin) is a once-daily product for the management of postherpetic neuralgia (PHN). Its Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug for the acute treatment of migraine attacks. Its Zipsor (diclofenac potassium liquid filled capsules) is a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain.
More

Webull offers kinds of Assertio Therapeutics Inc stock information, including NASDAQ:ASRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASRT stock news, and many more online research tools to help you make informed decisions.